Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Lipscomb

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancerMichael E Stokes, Catherine E Muehlenbein, Martin D Marciniak, et al.
Journal of the National Cancer Institute. Monographs|July 5, 2022
A History of Health Economics and Healthcare Delivery Research at the National Cancer InstituteV Paul Doria-Rose, Nancy Breen, Martin L Brown, et al.
Cancer|April 30, 2013
The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinomaWilliam A Hall, Lauren E Colbert, Yuan Liu, et al.
Journal of Geriatric Oncology|November 28, 2017
Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancerGretchen G Kimmick, Xiangrong Li, Steven T Fleming, et al.
International Journal of Environmental Research and Public Health|February 9, 2020
Improving Screening Uptake among Breast Cancer Survivors and Their First-Degree Relatives at Elevated Risk to Breast Cancer: Results and Implications of a Randomized Study in the State of GeorgiaJoseph Lipscomb, Cam Escoffery, Theresa W Gillespie, et al.
Journal of Oncology Practice|September 18, 2014
Individual, Area, and Provider Characteristics Associated With Care Received for Stages I to III Breast Cancer in a Multistate Region of AppalachiaGretchen G Kimmick, Fabian Camacho, Heath B Mackley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2016
What Predicts an Advanced-Stage Diagnosis of Breast Cancer? Sorting Out the Influence of Method of Detection, Access to Care, and Biologic FactorsJoseph Lipscomb, Steven T Fleming, Amy Trentham-Dietz, et al.
Journal of the National Cancer Institute|March 14, 2015
Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyondRobert A Hiatt, Caroline G Tai, Douglas W Blayney, et al.
Cancer|February 17, 2026
Receipt of guideline-concordant local and chemotherapy-based systemic therapy for patients with triple-negative breast cancer: 10-year survival outcomes in a multi-state population-based analysisJoseph Lipscomb, Gretchen G Kimmick, J Frank Wilson, et al.
Journal of the National Cancer Institute. Monographs|December 29, 2012
Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancerAnn S Hamilton, Xiao-Cheng Wu, Joseph Lipscomb, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancerMichael E Stokes, Catherine E Muehlenbein, Martin D Marciniak, et al.
Journal of the National Cancer Institute. Monographs|July 5, 2022
A History of Health Economics and Healthcare Delivery Research at the National Cancer InstituteV Paul Doria-Rose, Nancy Breen, Martin L Brown, et al.
Cancer|April 30, 2013
The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinomaWilliam A Hall, Lauren E Colbert, Yuan Liu, et al.
Journal of Geriatric Oncology|November 28, 2017
Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancerGretchen G Kimmick, Xiangrong Li, Steven T Fleming, et al.
International Journal of Environmental Research and Public Health|February 9, 2020
Improving Screening Uptake among Breast Cancer Survivors and Their First-Degree Relatives at Elevated Risk to Breast Cancer: Results and Implications of a Randomized Study in the State of GeorgiaJoseph Lipscomb, Cam Escoffery, Theresa W Gillespie, et al.
Journal of Oncology Practice|September 18, 2014
Individual, Area, and Provider Characteristics Associated With Care Received for Stages I to III Breast Cancer in a Multistate Region of AppalachiaGretchen G Kimmick, Fabian Camacho, Heath B Mackley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2016
What Predicts an Advanced-Stage Diagnosis of Breast Cancer? Sorting Out the Influence of Method of Detection, Access to Care, and Biologic FactorsJoseph Lipscomb, Steven T Fleming, Amy Trentham-Dietz, et al.
Journal of the National Cancer Institute|March 14, 2015
Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyondRobert A Hiatt, Caroline G Tai, Douglas W Blayney, et al.
Cancer|February 17, 2026
Receipt of guideline-concordant local and chemotherapy-based systemic therapy for patients with triple-negative breast cancer: 10-year survival outcomes in a multi-state population-based analysisJoseph Lipscomb, Gretchen G Kimmick, J Frank Wilson, et al.
Journal of the National Cancer Institute. Monographs|December 29, 2012
Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancerAnn S Hamilton, Xiao-Cheng Wu, Joseph Lipscomb, et al.
Pageof 13